Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2026-03-12 @ 6:49 PM
Study NCT ID:
NCT06644768
Status:
RECRUITING
Last Update Posted:
2025-10-09
First Post:
2024-10-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Sponsor:
Organization: